Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 1276 AL 1290

Astrocyte response in Alzheimer's disease: Good or bad?

Ismail A, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Yassen ASA, Alexiou A, Papadakis M, Batiha GE.

Brain Res. 2025 Dec 1;1868:149971. doi: 10.1016/j.brainres.2025.149971. Epub 2025 Oct 6.

The rhythm of decline: Circadian disruption in neurodegeneration

Singh J, Kumar D, Kaur J, Singh A.

J Food Drug Anal. 2025 Sep 18;33(3):224-240. doi: 10.38212/2224-6614.3553.

Brain somatic mutations in Alzheimer's disease: linking genetic mosaicism to neurodegeneration

Li Z, Zhang J, Liu Z, Yu L, Yang C, Zhang L, Xiang Z, Hu F, Brazh N, Shu K, Zhu LQ, Liu D.

Mol Neurodegener. 2025 Oct 9;20(1):104. doi: 10.1186/s13024-025-00895-0.

Gene-Exercise Interactions in Amyloid Metabolism and Clearance: Implications for Alzheimer's Disease

Astorino MF, Cipriano GL, Anchesi I, Lui M, Raffaele I, Calabrò M, Crisafulli C.

Int J Mol Sci. 2025 Oct 9;26(19):9816. doi: 10.3390/ijms26199816.

Nutraceuticals intervention in Alzheimer's disease: From farm to pharma

Chaithra PM, Rakshith BS, Logesh S, Kanthesh BM, Gopenath TS, Chang HM, Perry G, Singh SK.

J Alzheimers Dis. 2025 Dec;108(3):969-996. doi: 10.1177/13872877251385216. Epub 2025 Oct 17.

The role of neutrophils, red blood cells, and platelets in the pathology of Alzheimer's disease

Xu Y, Li X, Zhao Q, Xu X.

Ann Med. 2025 Dec;57(1):2575110. doi: 10.1080/07853890.2025.2575110. Epub 2025 Oct 24.

Expanding the scope of olfactory evaluation in Alzheimer's disease and related dementias (ADRD): A narrative review of the role for odor memory and recognition in AD/ADRD

Saak TM, Tervo JP, Motter JN, Overdevest JB.

J Alzheimers Dis. 2026 Mar;110(1_suppl):S68-S82. doi: 10.1177/13872877251389113. Epub 2025 Oct 27.

Cell Therapy Is a New Treatment Option to Prevent Neurodegenerative Changes and Restore Cognitive Functions in Alzheimer's Disease (Review)

Voronova AD, Karsuntseva EK, Shishkina VS, Fursa GA, Chadin AV, Shport SV, Stepanova OV, Chekhonin VP.

Bull Exp Biol Med. 2025 Aug;179(4):507-517. doi: 10.1007/s10517-025-06519-3. Epub 2025 Nov 4.

Amyloid-β as a cytokine-like somnogen: Rethinking its role in sleep homeostasis and Alzheimer's disease

Fernandez FX, Grandner MA.

J Alzheimers Dis. 2026 Jan;109(1):70-83. doi: 10.1177/13872877251392186. Epub 2025 Nov 5.

Genetic and functional dynamics of Butyrylcholinesterase in Alzheimer's disease: From mechanisms to clinical relevance

Prešern U, Goličnik M, Bavec A.

Chem Biol Interact. 2026 Jan 5;423:111809. doi: 10.1016/j.cbi.2025.111809. Epub 2025 Nov 5.

The association of the Wnt/β-catenin signaling pathway with Alzheimer's disease

Ma J, Liu Y, Lu D, Sun Q.

Neuropharmacology. 2026 Feb 1;283:110754. doi: 10.1016/j.neuropharm.2025.110754. Epub 2025 Nov 6.

Advances in non-human primate models for Alzheimer's disease research

Joho D, Sato K, Kumita W, Saido TC, Sasaki E, Sasaguri H.

Neurosci Res. 2025 Dec;221:104984. doi: 10.1016/j.neures.2025.104984. Epub 2025 Nov 8.

The Synergistic Role of ApoE4 and GSK3β in Alzheimer's Disease: Pathological Mechanisms and Therapeutic Implications

Li Q, Shang Y, Huang HC, Dai X, Lao F.

Mol Neurobiol. 2025 Nov 12;63(1):32. doi: 10.1007/s12035-025-05329-y.

The mtDNA-ZBP1 axis in alzheimer's disease: Mechanisms, pathogenesis, and therapeutic implications

Chen Y, Liu Y, Hu H, Li S.

Int Immunopharmacol. 2026 Jan 1;168(Pt 1):115853. doi: 10.1016/j.intimp.2025.115853. Epub 2025 Nov 18.

Mitochondria serve as indispensable components of neuron-glia crosstalk in the trajectory of Alzheimer's disease

Sardari M, Hosseinzadeh Sahafi O, Rezayof A.

Brain Res. 2026 Jan 1;1870:150040. doi: 10.1016/j.brainres.2025.150040. Epub 2025 Nov 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias